-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cardiff Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Cardiff Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$11.9M, a 21.8% decline year-over-year.
- Cardiff Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$43M, a 5.34% decline year-over-year.
- Cardiff Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$41.4M, a 7.07% decline from 2022.
- Cardiff Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$38.7M, a 36.8% decline from 2021.
- Cardiff Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$28.3M, a 46.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)